Open for bids Tender Germany ICB TOT Ref. 152587317

Medicines with the Active Ingredient Rituximab Tender - 152587317

Tender notice from Germany, published on 17 Nov 2026.

Executive Summary

Title/Summary: Tender for the supply of Rituximab infusion concentrate by AOK Sachsen-Anhalt in Magdeburg, Germany. The contract is set to begin on January 1, 2027, and will last for a maximum of 24 months, concluding on December 31, 2028.

Scope Of Work: This tender involves entering into non-exclusive discount agreements for the drug Rituximab in infusion concentrate form, according to German law. The agreements will be established under an 'open-house model,' allowing all eligible pharmaceutical companies to apply for participation. Interested companies must request participation documents and contracts from the provided contact. The earliest contract start date is January 1, 2027, with a maximum duration of 24 months, ending on December 31, 2028.

Qualification Criterion: Eligible bidders must be pharmaceutical companies that can fulfill the requirements outlined in the participation documents. They must submit fully completed and signed participation forms to enter into the discount agreements. There are no exclusivity clauses, and contracts can be signed at any time under the same conditions. Individual contract negotiations are not permitted.

Key facts

Summary
Medicines with the Active Ingredient Rituximab - in the Dosage Form Infusion Solution Concentrate (Atc: L01fa01)
TOT Ref. No.
152587317
Document Ref. No.
Login to see
Country
Germany
Notice type
Tender
Competition
ICB
Publication date
17 Nov 2026
Bid deadline
31 Oct 2028
EMD
Refer Document
Tender value
Refer Document
Purchaser ownership
Public
Financier
Self Financed

CPV classification

Purchaser details

Purchaser contact is for registered users

Login to see details

Tender details

Tender details are for registered users

Login to see details

Documents

Tender Notice
Login to view

Similar tenders

Germany Public Procurement Intelligence

Frequently asked questions

The last date to submit a bid for Medicines with the Active Ingredient Rituximab - in the Dosage Form Infusion Solution Concentrate (Atc: L01fa01) is 31 Oct 2028. Submit before this date to be considered.

This tender has been issued by AOK SAXONY - ANHALT in Germany.

The tender value is not disclosed; please refer to the tender document. EMD / bid security details are provided in the tender document.

This tender is Self Financed

The tender is classified under the following CPV code(s): 33600000 - Pharmaceutical products.

The tender notice and related documents are listed in the Documents section above. Select a document to view or download it. Please log in or register to access the documents. If you cannot find additional documents in the Documents section, please log in to your account and Send Document Request from your account section.

The TendersOnTime reference is 152587317. The purchaser document reference is available after login.

See the Similar Tenders section on this page or browse other tenders from Germany.

This tender falls under Materials and Products, Technology and Equipment in Germany. Suppliers in these sectors can track similar Germany tenders using CPV-based alerts.